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Abstract
Background: Feeding higher-energy prepartum is a common practice in the dairy industry. However, recent data
underscore how it could reduce performance, deepen negative energy balance, and augment inflammation and
oxidative stress in fresh cows. We tested the effectiveness of rumen-protected methionine in preventing the
negative effect of feeding a higher-energy prepartum. Multiparous Holstein cows were fed a control lower-energy
diet (CON, 1.24 Mcal/kg DM; high-straw) during the whole dry period (~50 d), or were switched to a higher-energy
(OVE, 1.54 Mcal/kg DM), or OVE plus Smartamine M (OVE + SM; Adisseo NA) during the last 21 d before calving.
Afterwards cows received the same lactation diet (1.75 Mcal/kg DM). Smartamine M was top-dressed on the OVE
diet (0.07% of DM) from -21 through 30 d in milk (DIM). Liver samples were obtained via percutaneous biopsy
at -10, 7 and 21 DIM. Expression of genes associated with energy and lipid metabolism, hepatokines, methionine
cycle, antioxidant capacity and inflammation was measured.
Results: Postpartal dry matter intake, milk yield, and energy-corrected milk were higher in CON and OVE + SM
compared with OVE. Furthermore, milk protein and fat percentages were greater in OVE + SM compared with CON
and OVE. Expression of the gluconeogenic gene PCK1 and the lipid-metabolism transcription regulator PPARA was
again greater with CON and OVE + SM compared with OVE. Expression of the lipoprotein synthesis enzyme MTTP
was lower in OVE + SM than CON or OVE. Similarly, the hepatokine FGF21, which correlates with severity of negative
energy balance, was increased postpartum only in OVE compared to the other two groups. These results indicate
greater liver metabolism and functions to support a greater production in OVE + SM. At 7 DIM, the enzyme GSR
involved in the synthesis of glutathione tended to be upregulated in OVE than CON-fed cows, suggesting a greater
antioxidant demand in overfed cows. Feeding OVE + SM resulted in lower similar expression of GSR compared
with CON. Expression of the methionine cycle enzymes SAHH and MTR, both of which help synthesize methionine
endogenously, was greater prepartum in OVE + SM compared with both CON and OVE, and at 7 DIM for CON and
OVE + SM compared with OVE, suggesting greater Met availability. It is noteworthy that DNMT3A, which utilizes
S-adenosylmethionine generated in the methionine cycle, was greater in OVE and OVE + SM indicating higher-energy
diets might enhance DNA methylation, thus, Met utilization.
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Conclusions: Data indicate that supplemental Smartamine M was able to compensate for the negative effect of
prepartal energy-overfeeding by alleviating the demand for intracellular antioxidants, thus, contributing to the increase
in production. Moreover Smartamine M improved hepatic lipid and glucose metabolism, leading to greater liver
function and better overall health.
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Background
The transition period, defined as last 3 weeks prepartum
through 3 weeks postpartum, is one of the most import-
ant stages of lactation in dairy cattle. Years of strong
genetic selection and improvement have allowed modern
dairy cows to reach high production performance, both
in quantity and quality. However, this has made the tran-
sition between late pregnancy to early lactation a signifi-
cant period of metabolic and immune challenges [1–3].
Because failure to adequately meet these challenges can
compromise production, induce metabolic diseases, and
increase rates of culling in early lactation [4], the man-
agement of the transition cow remains a focal point for
dairy producers.
Following the “steaming up” concept of RB Boutflour
[5], transition cows during the dry period were first trad-
itionally offered a high fiber/low energy density ration,
to then increase the energy density of the ration with a
lower fiber content in the last month of gestation (i.e.
“close-up” period). This early century practice is still em-
bedded in the modern dairy industry. However, multiple
studies have consistently reported negative effects of
prepartum energy overfeeding on cow health and prod-
uctivity. Among these, prepartum hyperglycemia and
hyperinsulinemia together with marked postpartum adi-
pose tissue mobilization (i.e., greater blood NEFA con-
centration) [6–11] have strong negative impact on
postpartal health indices [12–15].
Our general hypothesis was that supplementation with
rumen-protected methionine (Smartamine M, Adisseo
NA) could ameliorate the transition to lactation and the
health status of the cows, while controlling and reducing
the negative effects of prepartal excess energy. In fact,
methionine (Met) itself was able to increase both quan-
tity and quality of production [16, 17], controlling the
inflammatory and the oxidative stress status that
characterize the transition period [18–20]. These out-
comes are partly due to Met’s ability to enhance liver
function, reducing triacylglycerol accumulation and im-
proving the metabolic capacity of the liver to orchestrate
the metabolic transition into lactation [16–20]. Further-
more, Met itself, and several of its metabolites, display
an immunonutritional role both in humans [21–24] and
in dairy cows [16]. Therefore, in the present study we
used serum and plasma biomarkers coupled with
targeted hepatic transcriptome analysis from transition
cows fed prepartum either a control low energy, a
higher-energy, or a higher-energy diet supplemented
with rumen-protected Met. Production and immune re-
sponses have been published elsewhere [25].
Methods
Experimental design and dietary treatments
All procedures were approved by the Institutional
Animal Care and Use Committee (IACUC) of the
University of Illinois. Complete details of the experimen-
tal design and animal management have been reported
previously [25]. Briefly, 65 multiparous Holstein were
enrolled and completed the trail remaining healthy
throughout the length of the study. All cows were fed ad
libitum the same control lower-energy diet (CON; NEL =
1.24 Mcal/kg DM; no Met supplementation) during the
far-off dry period (i.e., -50 to -21 d relative to parturition).
Consequently, during the close-up period (i.e. -21 d to
calving), cows were randomly allocated to either a higher-
energy diet (OVE; NEL = 1.54 Mcal/kg DM), OVE plus
Smartamine M (OVE + SM; Adisseo, NA) or remained
on CON. The same basal lactation diet (NEL = 1.75
Mcal/kg DM) was fed to all cows postpartum until d
30 relative to parturition. Smartamine M was top-
dressed during the entire experiment over the OVE
or lactation diet from -21 through 30 d relative to
parturition at a rate of 0.07% of offered DM. For the
current study, only a subset of cows were considered for
blood biomarker (n = 10 per group) and hepatic gene ex-
pression (n = 8 per group) analyses.
Blood sampling and biomarker analysis
Blood was sampled at -26, -21, -10, 7, 14 and 21 d rela-
tive to parturition by coccygeal venipuncture using evac-
uated tubes (BD Vacutainer; BD and Co., Franklin Lakes,
NJ) containing either clot activator or lithium heparin
for serum and plasma, respectively. Blood was used for
determination of (i) metabolic biomarkers: cholesterol,
creatinine, growth hormone (GH), insulin-like growth
factor 1 (IGF-1), leptin, urea; (ii) liver health biomarkers:
albumin, bilirubin, ceruloplasmin, gamma-glutamyl-
transpeptidase (GGT), glutamic oxaloacetic transamin-
ase (GOT), haptoglobin, interleukin 6, serum amyloid A
(SAA); (iii) and oxidative status biomarkers: β-carotene,
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glutathione, nitric oxides (NOx, NO2, NO3), paraoxo-
nase, antioxidant capacity (oxygen radical absorbance
capacity, ORAC), total reactive oxygen metabolites
(ROM), tocopherol.
Concentration of albumin, cholesterol, bilirubin, cre-
atinine, urea, GOT, and GGT were assessed using kits
purchased from Instrumentation Laboratory (Lexington,
MA) using a clinical auto-analyzer (ILAB 600, Instru-
mentation Laboratory). Concentrations of ROM were
analyzed with the d-ROMs-test, purchased from Diacron
(Grosseto, Italy). Concentrations of haptoglobin, cerulo-
plasmin, paraoxonase and NOx were analyzed using the
methods previously described [26–28], adapting the pro-
cedures to a clinical auto-analyzer (ILAB 600, Instru-
mentation Laboratory). SAA and ORAC determinations
were performed using the Synergy 2 Multi-Detection
Microplate Reader (BioTek Instruments, Inc., Winooski,
VT). SAA concentration was assessed with a commercial
ELISA immunoassay kit (Tridelta Development Ltd.,
Maynooth, Co. Kildare, Ireland), while ORAC was deter-
mined measuring the fluorescent signal from a probe
(fluorescein) that decreases in the presence of radical
damage [29]. Quantification of GH, IGF-1, and leptin
concentration was as previously described [14]. Bovine
IL-6 (Cat. No. ESS0029; Thermo Scientific, Rockford, IL)
plasma concentration was determined using commercial
ELISA kits, while plasma vitamin A, vitamin E, and β-
carotene were extracted with hexane and analyzed by
reverse- phase HPLC using an Allsphere ODS-2 col-
umn (3 μm, 150 × 4.6 mm; Grace Davison Discovery
Sciences, Deerfield, IL), a UV detector set at 325 nm
(for vitamin A), 290 nm (for vitamin E), or 460 nm
(for β-carotene), and 80:20 methanol:tetrahydrofurane
as the mobile phase.
Hepatic gene expression analysis
Liver tissue was harvested via percutaneous biopsy
under local anesthesia at -10, 7 and 21 d relative to par-
turition. Tissue samples were immediately snap frozen
in liquid nitrogen and then stored at -80 °C. Complete
information about RNA extraction and qPCR proce-
dures can be found in Additional file 1. Briefly, RNA
samples were extracted from the frozen tissue and used
for cDNA synthesis using established protocols in our
laboratory [30]. The qPCR performed was SYBR Green-
based, using a 6-point standard curve. Genes selected
for transcript profiling are associated with (i) energy me-
tabolism: insulin like growth factor-1 (IGF1), pyruvate
carboxylase (PC), phosphoenolpyruvate carboxykinase 1
(PCK1), pyruvate dehydrogenase kinase 4 (PDK4); (ii)
fatty acid metabolism: acyl-CoA oxidase 1 (ACOX1),
apolipoprotein B (APOB), γ-butyrobetaine hydroxylase 1
(BBOX1), carnitine palmitoyltransferase 1A (CPT1A), 3-
hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2),
microsomal triglyceride transfer protein (MTTP), peroxi-
some proliferator activated receptor α (PPARA), solute
carrier family 22 member 5 (SLC22A5), trimethyllysine
hydroxylase, ε (TMLHE); (iii) hepatokines: angiopoietin like
4 (ANGPTL4), fibroblast growth factor 21 (FGF21); (iv) the
methionine cycle: betaine–homocysteine S-methyl
transferase (BHMT), betaine–homocysteine S-methyl
transferase 2 (BHMT2), DNA (cytosine-5-)-methyl-
transferase 1 (DNMT1), DNA (cytosine-5-)-methyl-
transferase 3 α (DNMT3A), methionine adenosy
ltransferase 1A (MAT1A), 5-methyltetrahydrofolate-
homocysteine methyltransferase (MTR), phosphatidyl-
ethanolamine N-methyltransferase (PEMT), S-adenosyl
homocysteine hydrolase (SAHH); (v) the antioxidant
system: cystathionine-beta-synthase (CBS), cysteine sulfi-
nic acid decarboxylase (CSAD), cystathionine gamma-
lyase (CTH), glutamate-cysteine ligase catalytic subunit
(GCLC), glutathione peroxidase 1 (GPX1), glutathione re-
ductase (GSR), glutathione synthetase (GSS), superoxide
dismutase 1, soluble (SOD1), superoxide dismutase 2,
mitochondrial (SOD2); (vi) and the inflammatory re-
sponse: ceruloplasmin (CP), haptoglobin (HP), nuclear
factor κB subunit 1 (NFKB1), retinoid X receptor α
(RXRA), serum amyloid A2 (SAA2), suppressor of
cytokine signaling 2 (SOCS2), signal transducer and
activator of transcription 3 (STAT3), signal transducer
and activator of transcription 5B (STAT5B). Primer
sequences and qPCR performances are reported in
Additional file 1.
Statistical analysis
After normalization with the geometric mean of the
internal control genes, qPCR data were log2 trans-
formed prior to statistical analysis to obtain a normal
distribution. Statistical analysis was performed with
SAS (v9.3). Both datasets (blood and qPCR) were sub-
jected to ANOVA and analyzed using repeated mea-
sures ANOVA with PROC MIXED. The statistical
model included diet (D; CON, OVE, and OVE + SM),
time (T; d -26, -21, -10, 7, 14, and 21 for blood bio-
markers, d -10, 7, and 21 for qPCR analysis) and
their interaction (D*T) as fixed effect. Cow, nested
within treatment, was the random effect. For blood
data, data pre-treatment at d-26 relative to partur-
ition, when available, were used as a covariate. The
Kenward-Roger statement was used for computing
the denominator degrees of freedom, while spatial
power was used as the covariance structure. Data
were considered significant at a P ≤ 0.05 using the
PDIFF statement in SAS. For ease of interpretation,
expression data reported in Table 1 and Fig. 1 are the
log2 back-transformed LSM that resulted from the
statistical analysis. Standard errors were also ad-
equately back-transformed.
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Table 1 Effect of feeding a control lower-energy diet (CON, 1.24 Mcal/kg DM; high-straw) during the whole dry period (~50 d), a
higher-energy (1.54 Mcal/kg DM) diet without (OVE) rumen-protected methionine during the last 21 d before calving, or OVE plus
rumen-protected methionine (Smartamine M; OVE + SM; Adisseo NA) from -21 d before calving through the first 30 d postpartum
on hepatic gene expression (relative mRNA abundance, log2 back-transformed LSM) in Holstein cows
Diet1 P-value3
CON OVE OVE + SM SE2 D T D*T
Energy metabolism
IGF1 1.91 1.97 2.41 0.22 0.19 <.0001 0.17
PC 0.24 0.23 0.20 0.02 0.24 <.0001 0.09
PCK1 0.33a 0.25b 0.31a 0.02 0.03 0.10 0.59
PDK4 0.34 0.31 0.78 0.37 0.35 0.03 0.98
Fatty acid oxidation, Lipoprotein and Cholesterol synthesis
ACOX1 1.34 1.21 1.27 0.07 0.41 0.75 0.61
APOB 1.93 1.67 1.82 0.11 0.22 0.32 0.42
BBOX1 0.39 0.36 0.38 0.02 0.61 0.04 0.96
CPT1A 0.13 0.13 0.14 0.01 0.89 <.0001 0.49
HMGCS2 1.13 1.00 0.93 0.10 0.32 0.22 0.56
MTTP 1.48a 1.50a 1.28b 0.08 0.05 0.02 0.84
PPARA 0.43 0.40 0.46 0.02 0.16 <.0001 0.03
SLC22A5 2.89 2.92 3.08 0.29 0.88 <.0001 0.14
TMLHE 0.42 0.40 0.41 0.02 0.68 0.003 0.39
Hepatokines
ANGPTL4 0.01 0.01 0.02 0.002 0.34 <.0001 0.03
FGF21 0.27 0.13 0.22 0.07 0.15 0.005 0.0006
Methionine cycle and methylation
BHMT 1.13 0.96 1.02 0.11 0.54 0.002 0.70
BHMT2 0.38 0.45 0.37 0.04 0.20 0.21 0.57
DNMT1 0.02 0.02 0.02 0.001 0.53 0.03 0.64
DNMT3A 0.99a 1.26b 1.20b 0.09 0.04 0.05 0.91
MAT1A 1.46 1.55 1.52 0.08 0.71 0.09 0.86
MTR 0.05a 0.03b 0.04ab 0.002 0.01 0.31 0.65
PEMT 0.33 0.29 0.30 0.02 0.31 0.07 0.95
SAHH 1.39 1.25 1.39 0.06 0.17 0.0003 0.0009
Antioxidant system
CBS 1.41 1.66 1.51 0.11 0.27 0.08 0.93
CSAD 0.23 0.26 0.22 0.04 0.64 0.0004 0.36
CTH 0.45 0.46 0.45 0.02 0.93 0.24 0.86
GCLC 0.06 0.06 0.05 0.004 0.80 0.01 0.35
GPX1 1.39 1.37 1.39 0.10 0.99 0.04 0.77
GSR 0.28 0.30 0.26 0.02 0.11 <.0001 0.11
GSS 0.45 0.49 0.46 0.02 0.34 0.78 0.95
SOD1 3.56 3.64 3.40 0.12 0.27 0.07 0.52
SOD2 4.06 4.08 4.10 0.21 0.99 0.92 0.53
Inflammatory response
CP 2.48 2.13 2.37 0.22 0.49 0.003 0.85
HP 0.18 0.13 0.14 0.09 0.89 0.01 0.48
NFKB1 2.29 2.14 2.48 0.14 0.25 0.04 0.83




Time affected all metabolic biomarkers (cholesterol, cre-
atinine, GH, IGF1, leptin, urea; T, P < 0.001). However,
no effect of diet or its interaction with time was detected
(D, D*T, P > 0.05) (Fig. 2).
Health status
No effects of diet or its interaction with time were sig-
nificant for haptoglobin or IL-6 concentration (D, D*T,
P > 0.05). Diet affected albumin concentration (D*T, P <
0.05), with greater (P < 0.05) postpartum concentrations
in OVE + SM compared with both other groups. The
overall concentration of total bilirubin, ceruloplasmin,
and serum amyloid A tended to be affected by diet (D,
P < 0.10), with greater levels (P < 0.05) in OVE cows
compared with CON (total bilirubin), OVE + SM
(ceruloplasmin), or both other groups (SAA). Diet also
affected GGT and GOT concentration, as OVE + SM had
greater (P < 0.05) overall GGT concentration (D, P <
0.10), especially postpartum (d 14 and 21), compared
with OVE, and lower (P < 0.05) GOT concentration post-
partum (d 7 and 14) (D*T, P < 0.05) compared with
CON cows. Time affected the concentration of all previ-
ous health biomarkers (T, P < 0.01).
Antioxidant and oxidative status
No effect of diet was detected for ORAC, total ROM
and tocopherol (D, P > 0.05). Total NOx also were not
affected by diet, despite the fact that concentrations of
both NO2 and NO3 had significant interactions or diet
effects (NO2, D*T, P < 0.10; NO3, D, P < 0.05, D*T, P <
0.10). Diet had a strong effect on GSH concentration
(D, P < 0.001), with greatest concentration (P < 0.05) in
OVE + SM cows compared with both other groups.
When interacting with time, diet tended to affect blood
concentration of β-carotene and retinol (D*T, P < 0.10).
For the first, the response was due to a greater (P <
0.05) concentration in OVE + SM cows compared with
CON at -21 and -10 d, and to a lower (P < 0.05) con-
centration in OVE compared with CON at 14 d relative
to parturition. In the case of retinol, the interaction was
due the increasing (P < 0.05) concentration postpartum
from 7 to 21 d in OVE + SM cows, while in CON
and OVE cows the concentration remained constant
(P > 0.05). This led to a greater (P < 0.05) retinol con-
centration in OVE + SM at 21 d postpartum compare
with OVE. Diet also affected paraoxonase concentra-
tion, with overall greater level (P < 0.05) in CON
compared with OVE and OVE + SM (D, P < 0.05).
This difference was due to greater (P < 0.05) concen-
tration in CON cows at -21, -10 and 7 d relative to
parturition (D*T, P < 0.05).
Gene expression
Energy metabolism
Cows fed the CON or OVE + SM diets had greater
PCK1 expression compared with OVE cows (D, P < 0.05).
Diet also affected the expression of the fatty acid metabol-
ism related genes MTTP (D, P < 0.05) and PPARA (D*T,
P < 0.05). Expression ofMTTP was in fact greater (P < 0.05)
in CON and OVE cows, compared with OVE + SM, while
PPARA expression was greater (P < 0.05) prepartum (-10 d)
for OVE + SM compared with CON and OVE, and lower
(P < 0.05) early postpartum (7 d) for OVE compared with
the other two groups.
Hepatokines and inflammation
Diet alone did not affect genes related to hepatokiens
and the inflammatory response (D, P > 0.05). However,
the hepatokines ANGPTL4 and FGF21 had a significant
interaction with time (D*T, P < 0.05). For FGF21 this
significance was due to a greater (P < 0.05) prepartal
expression in CON and OVE + SM compared with
OVE cows, while for ANPTL4 no differences among
dietary groups were detected across the analyzed time
points (P > 0.05).
Table 1 Effect of feeding a control lower-energy diet (CON, 1.24 Mcal/kg DM; high-straw) during the whole dry period (~50 d), a
higher-energy (1.54 Mcal/kg DM) diet without (OVE) rumen-protected methionine during the last 21 d before calving, or OVE plus
rumen-protected methionine (Smartamine M; OVE + SM; Adisseo NA) from -21 d before calving through the first 30 d postpartum
on hepatic gene expression (relative mRNA abundance, log2 back-transformed LSM) in Holstein cows (Continued)
RXRA 0.57 0.56 0.58 0.03 0.86 0.20 0.66
SAA2 0.01 0.01 0.02 0.002 0.68 0.02 0.95
SOCS2 2.09 1.84 2.26 0.24 0.44 0.16 0.60
STAT3 1.38 1.42 1.39 0.11 0.96 0.05 0.43
STAT5B 2.30 2.26 2.45 0.07 0.15 0.002 0.07
1Prepartum dietary treatment: CON = control energy, OVE =moderate energy, OVE + SM = OVE supplemented with rumen-protected methionine (Smartamine M,
Adisseo Inc.)
2SE = greatest standard error of the mean
3D = diet, T = time, D*T = diet by time interaction
a, bSignificant difference among dietary groups (P ≤ 0.05). Differences reported for genes with a significant (P ≤ 0.05) Diet effect
Vailati-Riboni et al. Journal of Animal Science and Biotechnology  (2017) 8:17 Page 5 of 12
Methionine cycle and antioxidant system
No genes concerning the antioxidant system were sig-
nificantly affected by diet, or its interaction with time
(D, D*T, P > 0.05). However, MTR and DNMT3A, genes
of the methionine cycle, had an overall effect of diet (D,
P < 0.05). Expression of MTR was greater (P < 0.05) in
CON compared with OVE, with OVE + SM having an
intermediate level of expression, while DNMT3A expres-
sion was greater (P < 0.05) in OVE and OVE + SA com-
pared with CON cows. Furthermore, SAHH expression
was greater (D*T, P < 0.05) prepartum in OVE + SM
cows compared with the other dietary groups; whereas,
expression was greater (P < 0.05) early postpartum (7 d)
in CON cows compared with OVE and OVE + SM.
Discussion
Overfeeding dairy cows in the weeks prior parturition
(e.g. close up period) has been previously linked with a
more pronounced negative energy balance postpartum,
due to bigger drops in voluntary dry matter intake
(DMI) along with sustained lipid mobilization and pos-
sible accumulation of triacylglycerol (TAG) in the liver
Fig. 1 Effect of feeding a control lower-energy diet (CON, 1.24 Mcal/kg DM; high-straw) during the whole dry period (~50 d), a higher-energy
(1.54 Mcal/kg DM) diet without (OVE) rumen-protected methionine during the last 21 d before calving, or OVE plus rumen-protected methionine
(Smartamine M; OVE + SM; Adisseo NA) from -21 d before calving through the first 30 d postpartum on hepatic gene expression (log2
back-transformed LSM) in Holstein cows
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[25]. The present study confirmed the overfeeding-
induced depression of DMI postpartum and hepatic
TAG accumulation [25]. Furthermore, despite previous
studies reporting that overfed cows were always able to
maintain similar levels of milk production as the
control-fed counterparts [31], these changes led to worse
milk performance including lower milk and energy cor-
rected milk yield [25].
As hypothesized, supplementation of rumen-protected
Met to a moderate energy diet was able to overcome the
detrimental effects of energy overfeeding. In fact, OVE +
SM cows compared with OVE had greater postpartal
DMI and better milk production, matching the perform-
ance of the control-fed group [25]. Despite the fact that
the improved DMI, likely a consequence of the im-
proved health status, could easily explain the improved
production performance, other cellular and physiologic
also likely were contributing factors.
The hepatic transcriptome revealed how Met supple-
mentation restored PCK1 expression (an important glu-
coneogenic gene) to the level of control-fed cows. At
least postpartum this could be explained by the higher
insulin concentration in OVE + SM [25], as hepatic
PCK1 mRNA expression is directly related to insulin
level [32]. The increased insulin concentration also could
explain why circulating glucose was lower in OVE + SM
cows [25] compared with CON, i.e. overfeeding alone does
not affect peripheral insulin resistance [9], and the in-
creased insulin concentration was not followed by changes
in GH or IGF1, hence, the improved milk production with
OVE + SM also might have resulted from an increase in
glucose availability directly channeled to peripheral tissues
and the mammary gland. In the latter case it would have
contributed to greater lactose production. Peripheral
tissues, i.e. adipose and muscle, rely mainly on GLUT4
(an insulin-dependent transporter) for glucose uptake,
while the mammary gland uses mainly GLUT1 (usually
described as insulin-independent) as the preferred glucose
transporter [33]. However, a recent study revealed that
insulin increases GLUT1 expression in bovine mam-
mary explants, thus, providing evidence of a func-
tional link between circulating insulin and mammary
glucose uptake [34].
Supplementing Met also increased both fat and pro-
tein percentage during the first week of lactation [25].
Because biomarkers of muscle catabolism were not
affected by diet (e.g. urea and creatinine) and DMI
was similar in CON and OVE + SM, we speculate that
Met itself, combined with higher circulating insulin,
might have been the primary cause of the improved
protein percentage. In fact, previous research demon-
strated that an increase in amino acid supply (e.g. ab-
omasal casein infusion) could markedly improve milk
protein yield, especially when the circulating level of
insulin was artificially raised through a clamp [35,
36]. The lower inflammation status and greater liver
function around calving in the OVE + SM cows (lower
concentrations of albumin and greater bilirubin, ceru-
loplasmin, GGT, GOT, and SAA) would have guaran-
teed higher availability of plasma amino acids [37] to
the mammary gland for protein synthesis. The in-
crease in fat content, which agrees with several previ-
ous studies [16, 38–41], might have been related to
cellular pathways involving Met and its methylated
compounds (e.g. choline [42]), which some data
Fig. 2 Effect of feeding a control lower-energy diet (CON, 1.24 Mcal/kg
DM; high-straw) during the whole dry period (~50 d), a higher-energy
(1.54 Mcal/kg DM) diet without (OVE) rumen-protected methionine
during the last 21 d before calving, or OVE plus rumen-protected
methionine (Smartamine M; OVE + SM; Adisseo NA) from -21 d before
calving through the first 30 d postpartum on endocrine profiles in
Holstein cows
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indicate are important for supporting milk fat synthe-
sis in cows [43].
As previously mentioned, overfeeding energy prepar-
tum led to hepatic TAG accumulation [25], a condition
that, if excessive, could become a potential burden for
proper liver function [2]. OVE cows, in fact, had signs of
impaired liver function and inflammatory condition
postpartum including lower concentrations of albumin
and greater bilirubin, ceruloplasmin, GGT, GOT, and
SAA (Table 2, Fig. 3). As hypothesized, supplemental
Met was able to correct these effects of the OVE diet.
Thus, as a primary outcome, OVE + SM cows had less
liver TAG accumulation [25] despite similar NEFA con-
centration between OVE and OVE + SM [25]. This was
at least in part due to greater PPARA expression with
Met supplementation.
Among the most important metabolic functions coor-
dinated by PPARα are LCFA uptake, intracellular activa-
tion, oxidation, and ketogenesis [44]. Thus its greater
expression in OVE + SM cows could have improved
NEFA handling, i.e. through greater oxidation. Further-
more, PCK1 is also involved in glyceroneogenesis, as it
can catalyze the production of glycerol-3-phospate for
use during fatty acid esterification [45]. Thus the
Table 2 Effect of feeding a control lower-energy diet (CON, 1.24 Mcal/kg DM; high-straw) during the whole dry period (~50 d), a
higher-energy (1.54 Mcal/kg DM) diet without (OVE) rumen-protected methionine during the last 21 d before calving, or OVE plus
rumen-protected methionine (Smartamine M; OVE + SM; Adisseo NA) from -21 d before calving through the first 30 d postpartum
on biomarker concentrations of metabolism, liver health, and oxidative status in Holstein cows
Diet1 P-values3
Items CON OVE OVE + SM SE2 D T D*T
Metabolism
Cholesterol, mmol/L 3.24 3.16 3.26 0.11 0.76 <.0001 0.71
Creatinine, μmol/L 97.60 98.88 97.68 1.53 0.77 <.0001 0.17
GH, ng/mL 5.75 4.79 6.95 1.08 0.23 <.0001 0.82
IGF-1, ng/mL 56.65 60.03 59.98 6.64 0.91 <.0001 0.69
Leptin, ng/mL 4.44 5.42 4.40 1.62 0.84 <.0001 0.29
Urea, mmol/L 5.20 5.05 5.05 0.18 0.77 <.0001 0.30
Liver health
Albumin, g/L 35.41 35.54 36.32 0.41 0.24 0.0002 0.05
Bilirubin , μmol/L 2.29a 3.38b 2.57ab 0.41 0.10 <.0001 0.57
Ceruloplasmin, μmol/L 2.77ab 2.91b 2.61a 0.09 0.006 <.0001 0.51
GGT, U/L 22.96a 25.21ab 26.85b 1.17 0.07 <.0001 0.008
GOT, U/L 84.76 90.30 81.71 5.61 0.48 <.0001 0.04
Haptoglobin, g/L 0.42 0.46 0.41 0.06 0.76 0.003 0.86
IL-6, pg/mL 530.63 586.37 412.76 98.56 0.37 0.001 0.67
SAA, μg/mL 35.55a 54.00b 34.77a 7.79 0.10 0.0005 0.58
Oxidative status
β-carotene, mg/100 mL 0.20 0.19 0.23 0.02 0.14 0.04 0.06
Liver GSH, mmol/L 953a 1281b 1693c 120 0.0002 0.05 0.14
NO2, μmol/L 6.03 6.66 6.80 0.45 0.44 0.01 0.09
NO3, μmol/L 18.65a 16.90b 16.77b 0.40 0.002 <.0001 0.08
NOx, μmol/L 24.61 23.54 23.67 0.56 0.31 <.0001 0.18
ORAC, TE mol/L 12,731 12,359 12,739 198 0.25 <.0001 0.66
Paraoxonase, U/mL 77.96a 68.41b 66.74b 2.68 0.01 <.0001 0.02
Retinol, μg/100 mL 46.39 41.79 43.42 3.10 0.44 0.0009 0.08
ROM, mg of H2O2/100 mL 14.01 12.99 13.44 0.49 0.31 <.0001 0.79
Tocopherol, μg/mL 3.67 3.68 3.16 0.44 0.46 <.0001 0.31
1Prepartum dietary treatment: CON = control energy, OVE =moderate energy, OVE + SM = OVE supplemented with rumen-protected methionine (Smartamine M,
Adisseo Inc.)
2SE = greatest standard error of the mean
3D = diet, T = time, D*T = diet by time interaction
a, b, cSignificant difference among dietary groups (P ≤ 0.05). Differen reported for biomarkers with a tendency (P ≤ 0.10) or a significan (P ≤ 0.05) Diet effect
Vailati-Riboni et al. Journal of Animal Science and Biotechnology  (2017) 8:17 Page 8 of 12
increase of its expression could have further improved
NEFA handling by the liver. The lower expression of
MTTP in the OVE + SM cows was lower indicated a po-
tentially lower capacity of these cows to synthesize and
export VLDL. However, the data from Bernabucci et al.
[46] indicated that apolipoprotein mRNA transcription
rather than MTTP might be the limiting step in the re-
packaging of TAG into lipoproteins, hence, explaining
the increase in concentration of plasma VLDL in OVE +
SM cows [25]. As a subsequent outcome, the improved
fatty acid metabolism in liver with Met supplementation
reduces the risk of liver dysfunction, an idea supported
by the biomarkers of liver function (e.g. greater albumin
and VLDL, and lower bilirubin) in OVE + SM cows [47].
Metabolic dysfunction and inflammatory events are
often linked through oxidative stress, a common out-
come to both scenarios [48–50]. The present study
partly confirmed the possible molecular mechanisms
through which prepartum overfeeding could cause an
increased concentration of oxidants proposed by Loor et
al. [51]. OVE did not cause changes in total ROM and
NOx, however, these cows had an impairment of the
antioxidant system. Despite similar blood antioxidant
capacity, paraoxonase concentration was in fact lower in
OVE cows, a condition that not only indicates liver dys-
function, but one that has been proven to lead to an in-
crease in the inflammatory status (confirmed by higher
ceruloplasmin and SAA), which notoriously causes an
increase in oxidative stress, and a reduction of antioxida-
tive protection during the early postpartum period [27,
52]. As for paraoxonase, postpartum (d 14) concentra-
tion of β-carotene, a precursor of vitamin A, which ex-
erts antioxidant effects [53], also was reduced in OVE
compared with CON.
Supplementation of rumen-protected Met has been
proven to benefit the oxidative status of periparturient
cows [19, 20], in large part because it is a precursor for
the biosynthesis of glutathione and taurine, two of the
most important cellular antioxidants [54, 55]. In the
present study, Met supplementation to cows fed a higher
Fig. 3 Effect of feeding a control lower-energy diet (CON, 1.24 Mcal/kg DM; high-straw) during the whole dry period (~50 d), a higher-energy
(1.54 Mcal/kg DM) diet without (OVE) rumen-protected methionine during the last 21 d before calving, or OVE plus rumen-protected methionine
(Smartamine M; OVE + SM; Adisseo NA) from -21 d before calving through the first 30 d postpartum on blood biomarkers of liver function and
antioxidant status in Holstein cows
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energy diet prepartum was able to improve their com-
promised antioxidant status. In fact, despite the lack of
changes in ROM or paraoxonase compared with OVE,
OVE + SM cows had greater glutathione concentrations,
even compared with CON, together with higher retinol
concentrations up to the level of control-fed cows. Con-
cerning retinol, its concentration is also regulated by the
hepatic synthesis of its carrier, retinol binding protein
[56]. Thus, a greater plasma retinol concentration, be-
sides suggesting a better antioxidant status, could also
be a response to the better liver functionality detected in
OVE + SM cows. Furthermore, GSR expression was de-
creased in OVE + SM cows to a similar level than OVE.
GSR encodes the protein glutathione reductase, a central
enzyme of cellular antioxidant defense, which reduces
oxidized glutathione disulfide to the sulfhydryl form
[57]. This further suggests a lesser oxidative status in
cows fed methionine, which despite having a greater
glutathione concentration seemed to have less of a need
to restore the pool of its active form.
Other health benefits of methionine supplementation
could also be noticed in the lower somatic cell count in
milk. For instance, OVE + SM cows compared with both
CON and OVE had lower milk SCC [25], a result that
further highlights the immunometabolic effects of me-
thionine and its metabolites [16, 21–23].
At a molecular level, the greater expression SAHH
prepartum in OVE + SM cows underscores that the in-
creased Met supply to the liver through supplementation
was directed through the methionine cycle, leading to
the higher glutathione concentrations. However, over-
feeding energy prepartum (e.g. OVE and OVE + SM)
seemed to reduce the overall expression of MTR, as if
regenerating Met was not a hepatic priority. This be-
comes relevant in early lactation, because after calving
the decrease in expression of both MTR and SAHH in
all groups indicated that cows might redirect the
circulating Met to the mammary gland for milk produc-
tion. To further complicate this scenario, the greater
DNMT3A expression in both OVE and OVE + SM cows
indicated a role of overfeeding in its regulation. Its
greater expression could indicate a higher need of
methyl groups from methionine by the liver, hence, in
light of the lower hepatic regeneration (e.g. lower MTR)
but greater utilization (e.g. higher DNMT3A) Met
supplementation (e.g. OVE + SM) favored the mammary
demand. The fact that milk production was restored to
the level of CON cows in the OVE + SM cows supports
this scenario.
The mechanisms by which prepartal overfeeding
causes a greater DNMT3A expression, increasing DNA
methylation and leading to greater consumption of
methyl groups from Met, are not clear. Insulin sensitivity
was previously associated with increased global methylation
[58], but overfeeding cows prepartum never led to its im-
pairment in our previous experiments [9, 10]. On the other
hand, levels of hepatic methylation were associated with
fatty liver disease in humans [59, 60]. Because OVE cows
had a greater hepatic TAG content [25], DNMT3A expres-
sion regulation could be explained by the alterations in lipid
metabolism.
Conclusions
Current results confirm the detrimental outcome (e.g.,
reduced DMI, compromised liver function, and higher
inflammatory status) of a higher-energy diet during the
close up period in dairy cows, thus, supporting the need
for energy restriction in the close-up period. However, if
the practice persists, dairy producers should improve the
diet methionine supply. In fact, supplemental rumen-
protected methionine was effective in reducing the
aforementioned effects, by (i) stimulating DMI and milk
production, (ii) improving hepatic fatty acid metabolism
and reducing TAG accumulation, (iii) improving general
biomarkers of liver function, and (iv) limiting the post-
partal negative effect of inflammation on the cow anti-
oxidant system. Further investigation is needed to assess
the effect of methionine supplementation to a prepartal
energy restricted diet during the close-up.
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